BioCardia (BCDA) Other financing activities (2016 - 2021)

BioCardia (BCDA) has reported Other financing activities for 4 consecutive years, with $5000.0 the latest figure, recorded in Q1 2021.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $5000.0 in Q1 2021; TTM through Dec 2021 was $5000.0, a 600.0% increase from a year earlier, with the FY2025 full-year figure at $5000.0, changed N/A from the prior year.
• Other financing activities was $5000.0 for Q1 2021 at BioCardia, up from -$1000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $118000.0 in Q4 2017 and troughed at -$1000.0 in Q4 2018.
• A 3-year average of $25500.0 and a median of $5000.0 in 2018 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities jumped 490.0% in 2017 and sank 100.85% in 2018, its largest moves.
• Over 3 years, Other financing activities stood at $118000.0 in 2017, then slumped by 100.85% to -$1000.0 in 2018, then soared by 600.0% to $5000.0 in 2021.
• The last three Other financing activities figures came in at $5000.0 (Q1 2021), -$1000.0 (Q4 2018), and $5000.0 (Q1 2018), per Business Quant data.